安帝君斯 AGEN 深 沪
等待开盘 03-28 09:30:00 美东时间
3.43
-0.010
-0.29%
华盛通- 最 高4.10
- 今 开3.44
- 成交量 17.33万股
- 最 低 2.90
- 昨 收 3.44
- 总市值 92.95万
- 52周最高 7.34
- 市盈率 静 --
- 换手率 63.96%
- 52周最低 1.38
- 委 比 -63.77%
- 总股本 0.00亿
- 历史最高 19.688
- 量 比 1.03
- 振 幅 34.88%
- 历史最低 0.41
- 每 手 1
- 风险率
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Earnings Scheduled For March 16, 2026
Companies Reporting Before The Bell • CytomX Therapeutics (NASDAQ:CTMX) is expe...
03-16 19:11
Agenus Triggers First $20M Contingent Payment Under Prior Collaboration Deal With Zydus Lifesciences
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that it has triggered the first $20 million contingent payment under its previously disclosed strategic collaboration with Zydus
03-10 19:34
Earnings Scheduled For November 10, 2025
Companies Reporting Before The Bell • CBAK Energy Tech (NASDAQ:CBAT) is likely ...
2025-11-10 19:12
Agenus Q4 2024 GAAP EPS $(2.04) Beats $(2.54) Estimate, Sales $26.84M Miss $30.27M Estimate
Agenus (NASDAQ:AGEN) reported quarterly losses of $(2.04) per share which beat the analyst consensus estimate of $(2.54) by 19.69 percent. This is a 21.54 percent increase over losses of $(2.60) per share from the same
2025-03-11 19:39
Earnings Scheduled For March 11, 2025
Companies Reporting Before The Bell • Exagen (NASDAQ:XGN) is projected to repor...
2025-03-11 16:32
Lipella Pharmaceuticals Granted U.S. Patent For "DELIVERY OF AGENTS USING METASTABLE LIPOSOMES (FOR LEAD DRUG HEMORRHAGIC CYSTITIS, CANCER, PAINFUL BLADDER SYNDROME)"
https://patentcenter.uspto.gov/applications/17829960?application=
2024-09-07 04:04
